The cost of developing a new drug can be as much as $11 billion. With these high costs, the mature pharma markets are stagnating. There is, however, an opportunity with emerging markets. Over the next five years, emerging markets will make up two-thirds of sales growth in the pharmaceutical industry. With this enormous opportunity to gain a competitive advantage, it is important for a company to know how to navigate this opportunity. The answer: big data. Analytics can help a company figure out who needs what drugs where, and for what price.
To learn more about how big data can help a company gain a competitive edge, check out the infographic below, presented by Spotfire.
